-
Reasons for rejection of section 18A Authority for medicinal cannabis
Since April 2021 60 applications for s18A authority to prescribe medicinal cannabis have been
refused:
• The majority (55) of applications were refused because further information requested was
not provided.
Joint Committees
55th Parliament (Current)
-
Welcome to today's hearing of the
Parliament of South Australia's Joint Committee on the Legalisation of Medicinal Cannabis.
Joint Committees
55th Parliament (Current)
-
What is the current cannabis use for males aged 18 to 25?
Joint Committees
55th Parliament (Current)
-
It also listed chronic health effects of cannabis use such as:1
• selective impairment of cognitive functioning, which may be greater with prolonged use
• development of a cannabis dependence syndrome and consequent withdrawal
• exacerbation of schizophrenia in affected individuals and in those who are predisposed to
experiencing psychosis, using THC containing cannabis may put them at an increased risk of
cannabis-induced psychosis
• an association between cannabis use disorder and schizophrenia among both males and
females, but larger among males than females, especially among those aged 16–25.2,3,4
• airway injury, lung inflammation, and impaired pulmonary defence against infection
• a higher prevalence of chronic and acute bronchitis
• impairment in foetal development when cannabis is used during pregnancy
• high level THC containing cannabis use for prolonged periods may result in the development of
cannabis hyperemesis syndrome.
Joint Committees
55th Parliament (Current)
-
Dear Secretary,
I am a long term Medical Cannabis user who has recently moved back to SA where I grew up
after many years in Tasmania where I ran the MCUAT patient support group.
Joint Committees
55th Parliament (Current)
-
Late last year we published the Cannabis in Australia 2022 Report, which
examined Australia's approach to medicinal cannabis, illicit cannabis and hemp in Australia.
Joint Committees
55th Parliament (Current)
-
Strict regulation is also
required in relation to the advertising and promotion of medicinal cannabis products to prevent
commercialisation of the cannabis industry.
Joint Committees
55th Parliament (Current)
-
… The Bedrocan Cannabis Flos cannot be distinguished from illicit
cannabis.
Joint Committees
55th Parliament (Current)
-
MedTEC Pharma’s Response to the South Australian Joint Committee on the
Legalisation of Medicinal Cannabis
Page 1 of 8
1.
Joint Committees
55th Parliament (Current)
-
Cannabis in South Australia -
What’s the Problem?
Joint Committees
55th Parliament (Current)